HCA Healthcare, Inc. $HCA Shares Sold by WINTON GROUP Ltd

WINTON GROUP Ltd trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 84.2% during the second quarter, Holdings Channel.com reports. The firm owned 1,160 shares of the company’s stock after selling 6,203 shares during the quarter. WINTON GROUP Ltd’s holdings in HCA Healthcare were worth $452,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. BlackRock Inc. bought a new position in shares of HCA Healthcare in the second quarter valued at approximately $5,069,974,000. Capital World Investors boosted its stake in HCA Healthcare by 0.8% during the 4th quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock valued at $2,334,040,000 after purchasing an additional 40,086 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of HCA Healthcare by 20.5% in the 2nd quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock worth $1,835,397,000 after buying an additional 799,761 shares in the last quarter. Geode Capital Management LLC boosted its stake in HCA Healthcare by 0.4% during the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock valued at $1,702,738,000 after buying an additional 13,565 shares in the last quarter. Finally, Norges Bank bought a new stake in HCA Healthcare in the fourth quarter worth about $1,262,513,000. 62.73% of the stock is currently owned by institutional investors.

More HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Higher BofA price target: Bank of America raised its price target for HCA Healthcare to $450 from $425, signaling improved confidence in the company’s outlook and potential upside. BofA Adjusts Price Target on HCA Healthcare
• Positive Sentiment: CHCP acquisition completed: HCA Healthcare finalized its purchase of The College of Health Care Professions, expanding its healthcare-education platform. The company said the transaction should help develop additional nurses and other healthcare professionals, potentially supporting long-term staffing needs across its network. HCA Healthcare Completes Acquisition of the College of Health Care Professions
• Positive Sentiment: Hospital investment: HCA plans to invest more than $32 million in Mission Health facilities across western North Carolina. The spending could improve capacity, equipment and service offerings, although the financial return is likely to develop over time. HCA Healthcare invests $32M in Mission Health hospitals
• Neutral Sentiment: Technology rollout advances: MEDITECH Expanse electronic health records are now live across 34 HCA hospitals in the Capital and North Florida divisions. The implementation may improve workflow and data coordination, but it also represents an ongoing execution and integration effort. MEDITECH Expanse EHR Live Across HCA Healthcare
• Neutral Sentiment: Leadership updates: HCA-affiliated hospitals in California and Idaho appointed new chief executive officers. The moves may support local operations, but they are unlikely to materially affect near-term earnings. HCA California hospital names CEO
• Negative Sentiment: Shareholder investigation: Pomerantz LLP announced an investigation into potential claims on behalf of HCA investors. The announcement does not establish wrongdoing, but the prospect of litigation or regulatory concerns creates headline and legal-risk overhang for the stock. Pomerantz Investor Alert on HCA Healthcare

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on HCA. Barclays lowered their price objective on shares of HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating on the stock in a research note on Monday, July 27th. Robert W. Baird dropped their price target on HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating on the stock in a report on Monday, July 27th. Mizuho reduced their price objective on HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating for the company in a research note on Tuesday, July 28th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $435.00 target price on shares of HCA Healthcare in a report on Tuesday, September 8th. Finally, Raymond James Financial set a $528.00 price objective on HCA Healthcare in a report on Tuesday, July 7th. Fourteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $462.64.

HCA Healthcare Price Performance

Shares of HCA opened at $423.13 on Wednesday. The company has a market capitalization of $91.61 billion, a price-to-earnings ratio of 14.17, a P/E/G ratio of 1.40 and a beta of 1.10. The business’s 50-day moving average is $405.17 and its 200-day moving average is $431.16. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. The firm had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm’s revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the firm posted $6.84 earnings per share. Equities research analysts expect that HCA Healthcare, Inc. will post 29.42 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.45%.

About HCA Healthcare

HCA Healthcare, Inc (NYSE:HCA) is a healthcare services company that operates hospitals and other healthcare facilities. Its network provides a broad range of medical services, including emergency care, inpatient and outpatient treatment, surgery, diagnostic services, and maternity care.

The company also operates ambulatory surgery centers, urgent care facilities, physician practices, and other outpatient locations. HCA Healthcare serves patients through facilities located across the United States, as well as through HCA Healthcare UK, its healthcare operations in the United Kingdom.

HCA Healthcare was founded in 1968 by Dr.